News | Ultrasound Imaging | August 23, 2019

Exo Imaging Raises $35 Million for Developmental Ultrasound Platform

Startup aims to provide an affordable portable ultrasound platform with high image fidelity, penetration depth and 3-D imaging

Exo Imaging Raises $35 Million for Developmental Ultrasound Platform

August 23, 2019 — Exo Imaging Inc. announced a $35 million Series B financing round for its high-performance ultrasound platform based on piezoelectric micromachined ultrasonic transducers (pMUT) and artificial intelligence (AI) for imaging and therapeutic applications.

Exo (pronounced “Echo”) is bringing diagnostic-grade medical imaging to the pocket of every caregiver and clinician worldwide, according to the company. It is developing an affordable medical ultrasound platform capable of exceptional image fidelity, penetration depth and 3-D imaging that still fits in the palm of your hand.

The Exo ultrasound platform combines advances in nano-materials, novel sensor technologies, advanced signal processing and computation with the economies of scale of semiconductor manufacturing to dramatically reduce the cost of imaging.

The company was founded in 2015 and has raised nearly $50M to date. Intel Capital led the Series B. Other investors in Exo include: Applied Ventures, Bold Capital, Creative Ventures, Longevity Vision Fund, Magnetar Capital, Nautilus Venture Partners, OSF Healthcare, Rising Tide Fund, Sony Innovation Fund and Wanxiang Healthcare Investments.

Exo CEO Sandeep Akkaraju said the Series B financing will enable the company to advance its products through the U.S. Food and Drug Administration (FDA) 510(k) clearance process and into commercialization. The company will use the proceeds to build out its team of engineering, sales and operations professionals. 

For more information: www.exo-imaging.com

Related Content

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 The Chinese start-up company Infervision launches its AI-based solution InferRead CT Lung Covid-19 also in Europe
News | Artificial Intelligence | March 31, 2020
March 31, 2020 — Lung infections generated by the coronavirus can be detected in...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Doctor in our hospital is using this intelligent system for accurate diagnosis

Doctor in our hospital is using this intelligent system for accurate diagnosis. (Photo: Business Wire)

News | Artificial Intelligence | March 31, 2020
March 31, 2020 — The Intelligent Evalua...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 behold.ai has developed the artificial intelligence-based red dot algorithm which can identify within 30 seconds abnormalities in chest X-rays. Wellbeing Software operates Cris, a widely used UK radiology Information System (RIS), which is installed in over 700 locations
News | Artificial Intelligence | March 31, 2020
March 31, 2020 — Two British companies at the leading edge of medical imaging technology are working together on a pl
AI tool predicts which patients newly infected with COVID-19 will eventually develop severe respiratory disease #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Artificial Intelligence | March 31, 2020
March 31, 2020 — An artificial intelligence tool accurately predicted which patients newly infected with the...
A physician working in a coronavirus care center nearby Daegu, South Korea, is using Lunit INSIGHT CXR to interpret chest X-ray image of a coronavirus patient. #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

A physician working in a coronavirus care center nearby Daegu, South Korea, is using Lunit INSIGHT CXR to interpret chest X-ray image of a coronavirus patient. Photo by Seoul National University Hospital

News | Artificial Intelligence | March 30, 2020
March 30, 2020 — Lunit, a medical AI software company that dev
CoronaCare is designed to help healthcare providers track COVID-19 (coronavirus) related symptoms of potentially infected patients. The platform enables communication with patients outside of facility walls and the ability to request the return of high-risk patients for more in-depth care. #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Coronavirus (COVID-19) | March 27, 2020
March 27, 2020 — PaxeraHealth has spent years building and be
AI vendor Infervision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis to improve the overall efficiency of the radiology department. It is being developed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19). #COVID19 #coronavirus #SARScov2

AI vendor Infervision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis to improve the overall efficiency of the radiology department. It is being developed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19).

Feature | Coronavirus (COVID-19) | March 27, 2020 | Jilian Liu, M.D., HIMSS Greater China
An older couple walked into the Hubei Provincial Hospital of Integrated Chinese and Western Medicine near their neigh
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Artificial Intelligence | March 24, 2020
March 24, 2020 — Qure.ai, a leading healthcare...